Company Filing History:
Years Active: 2011
Title: Dali Hu: Innovator in Biotechnology
Introduction
Dali Hu is a notable inventor based in Province, China. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic oligonucleotides.
Latest Patents
Dali Hu holds a patent for an oligonucleotide with the nucleotide sequence of 5'-cctcctcctcctcctcctcctcct-3′ (SEQ ID NO: 1). This innovative oligonucleotide inhibits the proliferation of human PBMC activated by TLR9 agonist and interferon production from human PBMC induced by TLR9 agonist, HSV-1, flu virus, and serum from SLE patients. Furthermore, it has been shown to rescue mice from cytokine-mediated lethal shock. This oligonucleotide has potential applications as a remedy for the treatment of systemic lupus erythematosus (SLE), sepsis, multiple organ dysfunction syndromes, and other immune-mediated disorders.
Career Highlights
Dali Hu is associated with Changchun Huapu Biotechnology Co. Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on treating serious health conditions.
Collaborations
Dali Hu collaborates with talented individuals in his field, including Liying Wang and Ran Sun, who contribute to his research initiatives.
Conclusion
Dali Hu's innovative work in biotechnology, particularly his patented oligonucleotide, showcases his commitment to advancing medical science and improving treatment options for immune-mediated disorders. His contributions are paving the way for future breakthroughs in the field.